Travere Therapeutics Inc (TVTX)
SG&A Expense Growth
19.76%
Quarterly · Period ending:
TVTX SG&A Expense Growth
Latest reported19.76%period ending
Latest reported19.76%period ending
TVTX Quarterly SG&A Growth (QoQ) (0.00% → 19.76%)
Latest values, visible window
High-resolution chart · PNG
TVTX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 19.7598% | |
| -21.0829% | |
| 17.6292% | |
| 13.4316% | |
| 4.6377% | |
| 4.8014% | |
| 5.916% | |
| 20.5545% | |
| -15.2469% | |
| 21.789% | |
| -22.2239% | |
| -0.5894% | |
| -5.5949% | |
| 14.8204% | |
| 20.0305% | |
| -1.0551% | |
| 13.232% | |
| 11.2014% | |
| 16.6644% | |
| 3.146% | |
| -4.9296% | |
| 2.9101% | |
| 11.8525% | |
| -8.6357% | |
| 5.5282% | |
| 47.0557% | |
| -24.3259% | |
| -23.5848% | |
| 19.2874% | |
| 25.8678% | |
| -0.5822% | |
| 4.012% | |
| -5.1685% | |
| -2.9588% | |
| 9.7497% | |
| -13.8131% | |
| 24.7458% | |
| -13.1831% | |
| -8.3792% | |
| 25.2316% | |
| 21.3333% | |
| -15.6969% | |
| 1.6945% | |
| 13.2846% | |
| 32.5584% | |
| -19.5451% | |
| -0.6018% | |
| 63.8083% | |
| 12.3667% | |
| 55.3335% | |
| 73.0406% | |
| -26.3788% | |
| 126.6136% | |
| 71,095.3179% | |
| 5.3667% | |
| -0.2991% | |
| -19.9308% | |
| 24.5195% | |
| -0.2314% | |
| 0.0331% | |
| -15.5307% | |
| 15.8201% | |
| 3.0333% | |
| -0.5964% | |
| -70.1336% | |
| 234.8244% | |
| -1.6297% | |
| -23.6626% | |
| 0% | |
| 39.377% | |
| -9.6564% | |
| 0% |